Ftse Mib
33.746,66
-1,60%
DAX
17.932,17
-1,10%
S&P 500
5.087,47
1,03%
NASDAQ Composite
15.832,42
1,12%
Bitcoin
58.883,90
-2,83%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Sophia Genetics SA (SOPH) Sophia Genetics SA (SOPH) Notizie

SOPH

Sophia Genetics (SOPH)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SOPH
DataOraFonteTitoloSimboloCompagnia
30/04/202413:05GlobeNewswire Inc.SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare ConferenceNASDAQ:SOPHSophia Genetics SA
23/04/202416:29GlobeNewswire Inc.SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024NASDAQ:SOPHSophia Genetics SA
23/04/202411:05PR Newswire (US)SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in AfricaNASDAQ:SOPHSophia Genetics SA
17/04/202412:05PR Newswire (US)SOPHiA GENETICS Announces Unilabs is using its AI Technology to Detect Homologous Recombination Deficiency (HRD)NASDAQ:SOPHSophia Genetics SA
04/04/202407:00PR Newswire (US)SOPHiA GENETICS and Strand Life Sciences Announce New Strategic PartnershipNASDAQ:SOPHSophia Genetics SA
02/04/202416:00PR Newswire (US)Laboratorio Barnafi-Krause is Live on SOPHiA DDM™NASDAQ:SOPHSophia Genetics SA
20/03/202415:00PR Newswire (US)SOPHiA GENETICS Announces First Homologous Recombination Deficiency (HRD) Customer in CanadaNASDAQ:SOPHSophia Genetics SA
15/03/202411:00PR Newswire (US)SOPHiA GENETICS and The French Kidney Cancer Research Network (UroCCR) Publish Results from Multiyear CollaborationNASDAQ:SOPHSophia Genetics SA
07/03/202418:07GlobeNewswire Inc.SOPHiA GENETICS to Present at the Barclays 26th Annual Global Healthcare ConferenceNASDAQ:SOPHSophia Genetics SA
05/03/202413:02Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:SOPHSophia Genetics SA
05/03/202413:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SOPHSophia Genetics SA
05/03/202412:45GlobeNewswire Inc.SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 ResultsNASDAQ:SOPHSophia Genetics SA
22/02/202414:45GlobeNewswire Inc.SOPHiA GENETICS to Participate in Fireside Chat at the 44th Annual TD Cowen Health Care ConferenceNASDAQ:SOPHSophia Genetics SA
20/02/202416:46GlobeNewswire Inc.SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full-Year 2023 on March 5, 2024NASDAQ:SOPHSophia Genetics SA
07/02/202413:31PR Newswire (US)SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in SpainNASDAQ:SOPHSophia Genetics SA
25/01/202416:50PR Newswire (US)SOPHiA GENETICS Supports Genetic Testing in BrazilNASDAQ:SOPHSophia Genetics SA
18/01/202421:00PR Newswire (US)SOPHiA GENETICS Enhances RareCyte Precision Biology Services PortfolioNASDAQ:SOPHSophia Genetics SA
15/01/202405:00PR Newswire (US)SOPHiA GENETICS and Karkinos Healthcare Forge Strategic Partnership to Advance Cancer Research in IndiaNASDAQ:SOPHSophia Genetics SA
10/01/202423:15PR Newswire (US)SOPHiA GENETICS Highlights Near-Term Growth Strategy at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:SOPHSophia Genetics SA
08/01/202415:08PR Newswire (US)Exactis Innovation and SOPHiA GENETICS Announce Collaboration on Multimodal Data AnalyticsNASDAQ:SOPHSophia Genetics SA
21/12/202313:00PR Newswire (US)Hôpital Saint-Louis Implements SOPHiA DDM™ Platform to Further Research of Myeloid DisordersNASDAQ:SOPHSophia Genetics SA
14/12/202318:43GlobeNewswire Inc.SOPHiA GENETICS to Present at the J.P. Morgan 2024 Healthcare ConferenceNASDAQ:SOPHSophia Genetics SA
07/12/202315:01PR Newswire (US)SOPHiA GENETICS Announces Expanded Suite of Liquid Biopsy OfferingsNASDAQ:SOPHSophia Genetics SA
30/11/202313:01PR Newswire (US)SOPHiA GENETICS Announces Expansion of Work with CHU de NîmesNASDAQ:SOPHSophia Genetics SA
28/11/202313:00PR Newswire (US)SOPHiA GENETICS Expands Relationship with Città della Salute e della Scienza di TorinoNASDAQ:SOPHSophia Genetics SA
17/11/202313:45PR Newswire (US)The Institute of Human Genetics, Polish Academy of Sciences (IHG PAS) is Live on SOPHiA GENETICSNASDAQ:SOPHSophia Genetics SA
07/11/202312:45PR Newswire (US)BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™NASDAQ:SOPHSophia Genetics SA
07/11/202312:30GlobeNewswire Inc.SOPHiA GENETICS Reports Financial Results for the Third Quarter of Fiscal 2023NASDAQ:SOPHSophia Genetics SA
24/10/202311:50GlobeNewswire Inc.SOPHiA GENETICS to Announce Financial Results for the Third Quarter of Fiscal 2023 on November 7, 2023NASDAQ:SOPHSophia Genetics SA
18/10/202314:00PR Newswire (US)SOPHiA GENETICS Enters New Collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca to Address Global Inequalities in Comprehensive Cancer CareNASDAQ:SOPHSophia Genetics SA
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SOPH

La tua Cronologia

BIT
STLAM
Stellantis NV
BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
ENI
Eni
BIT
STMMI
ST Microelectronics
BIT
RACE
Ferrari NV
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
TEN
Tenaris
BIT
TIT
Telecom Italia
BIT
LDO
Leonardo
BIT
SPM
Saipem
BIT
SRG
Snam
BIT
FBK
Finecobank
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network